Target intelligence / Profile preview

RNA, U6 small nuclear 881, pseudogene (RNU6-881P)

Target
RNU6-881P
Molecular classification
Pseudogene, Non-coding RNA pseudogene, Other
01

Overview

RNU6-881P (RNA, U6 small nuclear 881, pseudogene) is a pseudogene identified in the human genome, mapping to cytoband 9q34.13. It is cataloged in multiple gene databases (NCBI Gene: 106479956, Ensembl: ENSG00000252622, HGNC:47844), but does not encode a functional RNA or protein, nor does it appear to have any established biological activity or disease association. Pseudogenes are DNA segments similar to known genes but rendered non-functional through mutation or lack of regulatory elements, often serving as remnants of evolutionary processes. In rare cases, pseudogenes may have regulatory or ceRNA functions, but no such activity has been assigned to RNU6-881P[1][3][4][5][7]. RNU6-881P is not a valid therapeutic target and is classified as a pseudogene without known functional activity, disease roles, or drug interactions. Its listing as a target is incorrect.

Other names
RNU6-881PRNA, U6 small nuclear 881, pseudogene
02

Mechanism of action

None applicable. There is no known mechanism for any drugs acting via RNU6-881P, as it is not a functional molecule[3][5][7].

03

Biological functions

None directly attributed; pseudogenes are generally non-functional copies of other genes. The biological roles of pseudogenes can occasionally include competitive endogenous RNA (ceRNA) activity or regulation by acting as decoys for microRNAs, but no such function has been documented specifically for RNU6-881P[3][4].
04

Disease associations

None reported. No established association with disease has been described for RNU6-881P. Some pseudogenes show disease association through indirect regulatory effects, but there is no evidence for this with RNU6-881P[3][4][5][7].
05

Safety considerations

None relevant. As a pseudogene, RNU6-881P poses no therapeutic or clinical challenge[3][4].
06

Interacting drugs

None. There are no drugs reported to interact with or target RNU6-881P[3][5][7].
07

Biomarkers

None. RNU6-881P is not reported as a biomarker for disease or therapy[3][5][7].

Beyond the preview

Go deeper on RNA, U6 small nuclear 881, pseudogene (RNU6-881P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 881, pseudogene (RNU6-881P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call